PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Innovative research aims to improve wound healing and cancer therapy

Freiburg researcher Priscilla Briquez receives ERC Starting Grant for innovative approach to protein engineering

Innovative research aims to improve wound healing and cancer therapy
2023-10-27
(Press-News.org)

Jun.-Prof. Dr. Priscilla Briquez, junior professor at the Department of General and Visceral Surgery at the Freiburg University Medical Center and member of the Medical Faculty at the University of Freiburg, has received a European Research Council (ERC) Starting Grant from the European Commission. Her DRESSCODE project will receive a total of 1.5 million euros funding for five years. The project focuses on modifying proteins and developing new disease therapies.

“This support is a major opportunity for me to put together my own team and drive forward my research,” says Briquez. The focus of the project is on equipping protein cell membranes with therapeutic receptors. This produces cells which can perform specific healing functions, such as targeted bonding to medicines or pathogens. “The research project opens up new, significant opportunities for both regenerative medicine and cancer immunotherapy,” says Prof. Dr. Lutz Hein, Dean of the Medical Faculty of the University of Freiburg.

Innovations for wound healing and cancer immunotherapy

In the field of regenerative medicine, Briquez’s research approach can specifically alter the vascular endothelial growth factor (VEGF) receptor-2. This promotes the formation of blood vessels in chronic wounds and assists wound healing. In connection with cancer immunotherapy the project is researching the development of chimeric antigen receptors (CAR) on T-cells. These are receptors that are placed on immune cells in order to identify and attack cancer cells.

Briquez gained her PhD in 2016 at the Ecole Polytechnique Federale of Lausanne (EPFL), where she investigated the development of therapeutic proteins and biomaterials for wound healing. After that she was a postdoc at the Pritzker School of Molecular Engineering of the University of Chicago. There, she devoted herself to the field of molecular immunoengineering and cancer immunotherapy, before moving to the Department of General and Visceral Surgery at the Freiburg University Medical Center in 2021 where she was appointed junior professor.

With its Starting Grant funding line the ERC supports junior researchers who have already done outstanding work and who have the potential to assume a leading role in research.

Contact:
Corporate Communications
Freiburg University Medical Center
Tel. +49 761 270-84830
email: kommunikation@uniklinik-freiburg.de

University and Science Communication
University of Freiburg
Tel. +49 761 203-4302
email: kommunikation@zv.uni-freiburg.de

END


[Attachments] See images for this press release:
Innovative research aims to improve wound healing and cancer therapy Innovative research aims to improve wound healing and cancer therapy 2

ELSE PRESS RELEASES FROM THIS DATE:

Action plan for better data on migration and health

Action plan for better data on migration and health
2023-10-27
Despite rising global mobility, the state of migrant and refugee health data in European health systems is a concern, a new study shows. The analysis by an international coalition of universities, UN organizations, government representatives, and European institutions published in the journal The Lancet Regional Health Europe reveals that coverage of migrant and refugee data remains inconsistent and of suboptimal quality. According to the study this issue is not due to a lack of knowledge or technological resources ...

FDA approves muscular dystrophy drug built on Children’s National research 

2023-10-27
WASHINGTON (October 27, 2023) – Boys with Duchenne muscular dystrophy (DMD) have a clinically proven, new treatment option with the Food and Drug Administration’s approval Thursday of vamorolone, a steroidal-type, anti-inflammatory drug developed based on research performed at Children’s National Hospital.    Created by ReveraGen BioPharma Inc., vamorolone has a molecular structure similar to traditional corticosteroids, which are currently used to treat DMD. Yet its structure was found to be chemically different enough to reduce unwanted side effects, including brittle bones and reduced stature. Nearly two decades ago, ReveraGen leaders – President and ...

Electrodes with hollow nanotubes improve performance of potassium-ion batteries

Electrodes with hollow nanotubes improve performance of potassium-ion batteries
2023-10-27
Researchers who are working to find alternatives to lithium-ion batteries have turned their attention to potassium-ion batteries. Potassium is an abundant resource and the technology functions in much the same way as lithium-ion batteries, but these batteries have not been developed at a large scale because the ionic radius causes problems in energy storage and substandard electrochemical performance.   To solve this problem, researchers are considering NiCo2Se4, a bimetallic selenide, to create sphere-shaped electrodes. The spheres are constructed with NiCo2Se4 nanotubes, which improve ...

USDA grant will help MU researchers address opioid epidemic in rural Missouri

USDA grant will help MU researchers address opioid epidemic in rural Missouri
2023-10-27
COLUMBIA, Mo. -- Childhood trauma is a key risk factor for future substance use disorder, overdose, and suicide. This is particularly problematic in rural areas where children experience higher rates of adverse childhood experiences (ACEs). ACEs are commonly defined as physical and emotional abuse and neglect, sexual abuse, parental separation or divorce, intimate partner violence, and having household members with serious mental illness, substance use disorder, or a history of incarceration. Now, a three-year, U.S. Department of Agriculture (USDA) grant awarded to the University of Missouri will help virtually train various members of the workforce — ...

UiB researchers solve protein mystery

UiB researchers solve protein mystery
2023-10-27
Proteins are key to all processes in our cells and understanding their functions and regulation is of major importance. “For many years, we have known that nearly all human proteins are modified by a specific chemical group, but its functional impact has remained undefined”, says professor Thomas Arnesen at the Department of Biomedicine, University of Bergen. He explains: “One of the most common protein modifications in human cells is N-terminal acetylation, which is an addition of a small chemical group (acetyl) at the starting tip (N-terminus) of a protein. The ...

Protein root discovery seals future of climate proof plants

2023-10-27
Researchers have discovered a protein that seals plant roots to regulate the uptake of nutrients and water from the soil, the discovery could help develop climate proof crops that require less water and chemical fertilizers. Researchers from the University of Nottingham identified new components of the lignin barrier in plant roots and the specific function of dirigent proteins (DPs), located in the root endodermis that control water and nutrient uptake. Their findings have been published today in Science Direct. Plant roots function by absorbing ...

A relational framework for microbiome research that includes Indigenous communities

2023-10-27
Research on the trillions of microorganisms that make up a person’s microbiome can lead to medical breakthroughs to treat diseases like inflammatory bowel syndrome and diabetes. According to Alyssa Bader, a Tsimshian Assistant Professor in the Department of Anthropology at McGill University, microbiome samples from Indigenous communities have the potential to further Western medicine, but those same communities often have been excluded from the research process and may miss out on the benefits that result from their contributions to science. ...

City of Hope part of successful international Phase 3 clinical trial evaluating sotorasib medication combination for patients with metastatic colorectal cancer

City of Hope part of successful international Phase 3 clinical trial evaluating sotorasib medication combination for patients with metastatic colorectal cancer
2023-10-27
LOS ANGELES — An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compared to standard of care when offered a combination treatment of KRAS inhibitor sotorasib and monoclonal antibody panitumumab. City of Hope, one of the largest cancer research and treatment organizations in the United States, was a participating site and a City of Hope researcher is the lead author of the The New England Journal of Medicine study published this week. Standard ...

Team synthesizes a new polyoxometalate-based metal-organic complex

Team synthesizes a new polyoxometalate-based metal-organic complex
2023-10-27
A research team has synthesized a new polyoxometalate-based metal-organic complex that they then tested as a catalyst for the oxidation reactions of various sulfides. They found that the complex possesses excellent catalytic performance, good reusability, and structural stability.   The team’s work is published in the journal Polyoxometalates on October 19, 2023.   Scientists in many fields have explored the selective oxidation of sulfides to sulfoxides. Sulfoxides are organic compounds that contain sulfur and oxygen. These sulfoxides are high value-added chemicals in pharmaceuticals, agrochemistry, ...

The sunscreen paradox: McGill University researchers warn of ‘false sense of security’

2023-10-27
Sunscreen usage is climbing, but so are melanoma and skin cancer rates: this, researchers say, is the sunscreen paradox. “The problem is that people use sunscreen as a ‘permission slip’ to tan,” said Dr. Ivan Litvinov, an Associate Professor in the Department of Medicine and Chair of the Dermatology Division at McGill University and co-author with Dr. Sandra Peláez, Dr. Richie Jeremian and Dr. Pingxing Xie of two recent studies that explore the sunscreen paradox. “People think they are protected from skin cancer ...

LAST 30 PRESS RELEASES:

Norbert Holtkamp appointed director of Fermi National Accelerator Laboratory

New agentic AI platform accelerates advanced optics design

Biologists discover neurons use physical signals — not electricity — to stabilize communication

Researchers discover that a hormone can access the brain by hitchhiking

University of Oklahoma researcher awarded funding to pursue AI-powered material design

Exploring how the visual system recovers following injury

Support for parents with infants at pediatric check-ups leads to better reading and math skills in elementary school

Kids’ behavioral health is a growing share of family health costs

Day & night: Cancer disrupts the brain’s natural rhythm

COVID-19 vaccination significantly reduces risk to pregnant women and baby

The role of vaccination in maternal and perinatal outcomes associated with COVID-19 in pregnancy

Mayo Clinic smartwatch system helps parents shorten and defuse children's severe tantrums early

Behavioral health spending spikes to 40% of all children’s health expenditures, nearly doubling in a decade

Digital cognitive behavioral treatment for generalized anxiety disorder

Expenditures for pediatric behavioral health care over time and estimated family financial burden

Air conditioning in nursing homes and mortality during extreme heat

The Alps to lose a record number of glaciers in the next decade

What makes a good proton conductor?

New science reporting guide published for journalists in Bulgaria

New international study reveals major survival gaps among children with cancer

New science reporting guide published for journalists in Turkey

Scientists develop a smarter mRNA therapy that knows which cells to target

Neuroanatomy-informed brain–machine hybrid intelligence for robust acoustic target detection

Eight SwRI hydrogen projects funded by ENERGYWERX

The Lundquist Institute and its start-up company Vitalex Biosciences Announces Strategic Advancement of Second-Generation fungal Vaccine VXV-01 through Phase 1 Trials under $40 Million Competitive Con

Fine particles in pollution are associated with early signs of autoimmune disease

Review article | Towards a Global Ground-Based Earth Observatory (GGBEO): Leveraging existing systems and networks

Penn and UMich create world’s smallest programmable, autonomous robots

Cleveland researchers launch first major study to address ‘hidden performance killer’ in athletes

To connect across politics, try saying what you oppose

[Press-News.org] Innovative research aims to improve wound healing and cancer therapy
Freiburg researcher Priscilla Briquez receives ERC Starting Grant for innovative approach to protein engineering